World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ClinicalTrials.gov
Last refreshed on: 12 December 2020
Main ID:  NCT03266432
Date of registration: 28/08/2017
Prospective Registration: Yes
Primary sponsor: Assiut University
Public title: Thromboelastometry Guided DIC Prevention After Cesarean Section in Pregnant Women With Placenta Previa DIC
Scientific title: Thromboelastometry Guided Disseminated Intravascular Coagulation Prevention After Cesarean Section in Pregnant Women With Placenta Previa
Date of first enrolment: August 28, 2017
Target sample size: 60
Recruitment status: Recruiting
URL:  https://clinicaltrials.gov/show/NCT03266432
Study type:  Interventional
Study design:  Allocation: N/A. Intervention model: Single Group Assignment. Primary purpose: Prevention. Masking: None (Open Label).  
Phase:  N/A
Countries of recruitment
Egypt
Contacts
Name:     Alaa Mohamed Ahmed Attia, MD
Address: 
Telephone: 01099923117
Email: alaa.atya@med.au.edu.eg
Affiliation: 
Name:     ragaa Ahmed Herdan, MD
Address: 
Telephone:
Email:
Affiliation:  Assiut university hopitals
Name:     Mohamed kilany, Master
Address: 
Telephone: 00201090030029
Email: mohamedkelany@aun.edu.eg
Affiliation: 
Key inclusion & exclusion criteria

Inclusion Criteria:

- ASA physical status I or II

- Age: = 18 years

- Patients with all types of placenta previa

- Eligible for general anesthesia

- Elective cesarean section

- Singleton term pregnancy

- Normal coagulation profile: prothrombin time (PT), activated partial thromboplastin
time (aPTT), the platelet count, fibrinogen level

Exclusion Criteria:

- Parturient refusal

- Known coagulopathy

- Women with a history of cardiac, respiratory, renal, neurologic or endocrine diseases.

- Eclampsia and preeclampsia

- Emergency surgeries

- Foetal abnormalities

- Drug induced thrombocytopenia as antibiotics



Age minimum: 18 Years
Age maximum: 45 Years
Gender: Female
Health Condition(s) or Problem(s) studied
DIC Syndrome
Intervention(s)
Other: blood samples
Primary Outcome(s)
prevention of Postoperative development of DIC [Time Frame: from time of operation till 48 hours postopertive]
Secondary Outcome(s)
prevention of Complications of massive transfusion [Time Frame: from time of operation till 48 hours postoperative]
heart rate [Time Frame: from time of operation till 48 hours postoperative]
Systolic blood pressure [Time Frame: from time of operation till 48 hours postoperative]
diastolic blood pressure [Time Frame: from time of operation till 48 hours postoperative]
Secondary ID(s)
thromboelastometryDIC
Source(s) of Monetary Support
Please refer to primary and secondary sponsors
Secondary Sponsor(s)
Ethics review
Results
Results available:
Date Posted:
Date Completed:
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history